Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum

Por Condac, Eduard, Dale, George L, Bender-Neal, Diane, Ferencz, Beatrix, Towner, Rheal, Hinsdale, Myron E
Publicado em 2009

PDGFRβ signaling regulates local inflammation and synergizes with hypercholesterolemia to promote atherosclerosis

Por He, Chaoyong, Medley, Shayna C., Hu, Taishan, Hinsdale, Myron E., Lupu, Florea, Virmani, Renu, Olson, Lorin E.
Publicado no Nat Commun (2015)

Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis

Por Condac, Eduard, Silasi-Mansat, Robert, Kosanke, Stanley, Schoeb, Trenton, Towner, Rheal, Lupu, Florea, Cummings, Richard D., Hinsdale, Myron E.
Publicado em 2007

Apo E structure determines VLDL clearance and atherosclerosis risk in mice

Por Knouff, Christopher, Hinsdale, Myron E., Mezdour, Hafid, Altenburg, Michael K., Watanabe, Masahiko, Quarfordt, Steven H., Sullivan, Patrick M., Maeda, Nobuyo
Publicado em 1999

Homozygosity for Frameshift Mutations in XYLT2 Result in a Spondylo-Ocular Syndrome with Bone Fragility, Cataracts, and Hearing Defects

Por Munns, Craig F., Fahiminiya, Somayyeh, Poudel, Nabin, Munteanu, Maria Cristina, Majewski, Jacek, Sillence, David O., Metcalf, Jordan P., Biggin, Andrew, Glorieux, Francis, Fassier, François, Rauch, Frank, Hinsdale, Myron E.
Publicado no Am J Hum Genet (2015)